['dyspepsia']
['z-338']

        Inclusion Criteria:

          -  Subjects to provide written informed consent prior to any study procedures being
             performed

          -  Subjects with a diagnosis of FD (postprandial distress syndrome) as defined by the
             Rome III Criteria

          -  Subjects must present Postprandial Fullness or Early Satiation as the most bothersome
             symptom during the 6 months prior to informed consent.

          -  Subjects must have a normal endoscopy result within the 6 months (3 months in case of
             subjects who are Helicobacter pylori positive) prior to informed consent or during the
             screening period.

        Exclusion Criteria:

          -  Subjects on PPI(s) who are unable to discontinue PPI medication by the end of the
             screening period

          -  Subjects taking drugs that affect gut motility, gut sensitivity and/or acid secretion
             who are unable to discontinue these drugs by the end of the screening period

          -  Subjects who have received H. pylori eradication therapy during the 3 months prior to
             informed consent

          -  Subjects with confirmed organic gastrointestinal disease

          -  Subjects presenting with predominant complaints relieved by stool movements (irritable
             bowel syndrome)

          -  Subjects presenting with predominant GORD symptoms

          -  Subjects presenting with predominant complaints of chronic idiopathic nausea

          -  Subjects with Type I or Type II diabetes

          -  Subjects with body mass index (BMI) over 30 kg/m2

          -  Subjects with any condition which, in the opinion of the Investigator, makes the
             subject unsuitable for entry into the study
      